USG Cover Coat

Product Description

USG Cover Coat is a finishing compound manufactured by United States Gypsum Company (USG), one of the largest gypsum and drywall product manufacturers in North America. Cover Coat is classified as a high-build, ready-mixed finishing compound designed to be applied over primed surfaces, joint compound layers, and interior gypsum board assemblies to produce smooth, paintable wall and ceiling surfaces. The product was marketed primarily for use in commercial and residential construction as a topping and texturing material.

USG has operated in the building materials industry for well over a century, and its product lines — including joint compounds, plasters, and specialty finishing materials — were staples of American construction throughout the mid-to-late twentieth century. Cover Coat specifically was positioned as a professional-grade finishing product intended for use by plasterers, drywall finishers, and interior construction trades in both new construction and renovation work. Given USG’s broad reach across commercial, industrial, and institutional building sectors, Cover Coat was used in a wide variety of settings, including hospitals, schools, office buildings, and industrial facilities.

Asbestos Content

The specific asbestos content of USG Cover Coat has been a subject of civil litigation. Plaintiffs alleged that Cover Coat contained asbestos-containing materials as part of its formulation during certain periods of production. While USG has not universally conceded the presence of asbestos in all Cover Coat formulations across all production years, litigation records document claims asserting that some batches or versions of the product contained asbestos minerals — most commonly chrysotile — incorporated as a reinforcing agent or to improve the product’s workability, adhesion, and resistance to cracking.

Asbestos was widely used in joint compounds and finishing products by multiple manufacturers during the mid-twentieth century because of its fibrous structure, which helped bind the compound, reduce shrinkage during drying, and improve spreadability. Regulatory pressure from the U.S. Environmental Protection Agency (EPA) and the Occupational Safety and Health Administration (OSHA) during the 1970s led many manufacturers to reformulate or discontinue asbestos use. The Asbestos Hazard Emergency Response Act (AHERA), enacted in 1986, further established regulatory frameworks for identifying and managing asbestos-containing building materials in schools and public structures, underscoring the widespread recognition that finishing and joint compound products of earlier eras warranted scrutiny.

Because Cover Coat was applied in multiple coats and often sanded to a smooth finish, any asbestos fibers present in the compound’s formulation would have been directly relevant to occupational exposure risk during those work processes.

How Workers Were Exposed

Workers in industrial and commercial construction settings represent the primary population documented in litigation involving USG Cover Coat. Litigation records document allegations that workers experienced occupational asbestos exposure through the routine application, sanding, mixing, and cleanup tasks associated with finishing compound products.

The nature of finishing compound work is inherently dust-generating. When Cover Coat or similar topping compounds were sanded — a necessary step to achieve the smooth, uniform surface required for painting — fine particulate dust was released into the work environment. If asbestos fibers were present in the compound’s formulation, plaintiffs alleged that this sanding process would have aerosolized respirable asbestos fibers, creating an inhalation hazard for workers in close proximity.

Industrial workers generally — including those employed in large-scale commercial or industrial construction and renovation projects — are among those identified in litigation records as having been exposed to Cover Coat during the course of their work. These workers often labored in enclosed or poorly ventilated spaces where dust accumulation was significant, and where the protections now required under OSHA’s asbestos standards (29 CFR 1926.1101 for construction; 29 CFR 1910.1001 for general industry) were not yet in place or were not enforced.

Secondary exposure was also a concern. Workers in adjacent trades — electricians, painters, HVAC technicians, and others who worked in spaces where finishing compounds were being applied and sanded — may have inhaled airborne fibers without directly handling the product themselves. Litigation records document allegations from workers in multiple trades who claimed exposure to finishing compound dust generated by others on the same job sites.

The latency period for asbestos-related diseases, which typically ranges from ten to fifty years following initial exposure, means that workers exposed to Cover Coat during the peak construction decades of the 1950s through the 1970s may be experiencing related health consequences today. Documented asbestos-related conditions linked to finishing compound exposure in litigation have included mesothelioma, asbestosis, lung cancer, and pleural disease.

USG Cover Coat falls within Tier 2 of asbestos product litigation, meaning that claims involving this product are pursued through the civil court system rather than through an established asbestos bankruptcy trust fund. USG Corporation has not, as of the time of this writing, established a dedicated asbestos settlement trust of the type created by companies that resolved their asbestos liabilities through Chapter 11 bankruptcy reorganization.

Civil Litigation

Litigation records document that plaintiffs have filed civil lawsuits naming United States Gypsum as a defendant in connection with asbestos exposure from its finishing and joint compound product lines, including Cover Coat. These cases have been filed in state and federal courts across the country. Plaintiffs alleged that USG knew or should have known of the hazards associated with asbestos in its products and failed to provide adequate warnings to workers who used or were exposed to those products.

Individuals diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related conditions who have a documented history of occupational exposure to USG Cover Coat — or who worked in environments where Cover Coat was applied and sanded — may have grounds to pursue a civil claim. Litigation of this type can seek compensation for medical expenses, lost wages, pain and suffering, and, where applicable, wrongful death damages.

Steps for Affected Workers

Individuals who believe they were exposed to asbestos through USG Cover Coat should consider the following:

  • Document work history: Employment records, union membership records, coworker testimony, and job site documentation can help establish the nature and duration of exposure.
  • Obtain a medical diagnosis: A formal diagnosis from a pulmonologist or occupational medicine specialist is a necessary foundation for any legal claim.
  • Consult an asbestos attorney: Attorneys experienced in asbestos litigation can evaluate whether civil litigation against USG or other responsible parties is appropriate given the individual’s exposure history and diagnosis.
  • Explore trust fund eligibility: Even where a direct USG claim proceeds through litigation, exposure to multiple asbestos products is common in construction work. Workers may separately qualify for claims against asbestos bankruptcy trusts established by other manufacturers whose products were present on the same job sites.

Statutes of limitations for asbestos claims vary by state and typically begin running from the date of diagnosis, not the date of exposure. Prompt consultation with qualified legal counsel is strongly advised.